| RS2143731723 |
CCBE1
|
Health Risk |
Likely pathogenic |
— |
| RS2143731999 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group A, Fanconi anemia complementation group A |
| RS2143732272 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2143733843 |
CCDC40
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS2143735173 |
CCDC40
|
Health Risk |
Pathogenic |
— |
| RS2143735253 |
JUP
|
Health Risk |
Conflicting classifications of pathogenicity |
Naxos disease, Arrhythmogenic right ventricular dysplasia 12 |
| RS2143737350 |
MKS1
|
Health Risk |
Likely pathogenic |
Meckel-Gruber syndrome, Joubert syndrome |
| RS2143737457 |
MKS1
|
Health Risk |
Pathogenic/Likely pathogenic |
Joubert syndrome 28, Joubert syndrome |
| RS2143742869 |
MKS1
|
Health Risk |
Likely pathogenic |
Meckel-Gruber syndrome, Joubert syndrome |
| RS2143742992 |
RAD51C
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS2143744121 |
RAD51C
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS2143744476 |
MKS1
|
Health Risk |
Pathogenic |
Meckel-Gruber syndrome, Joubert syndrome |
| RS2143744820 |
MKS1
|
Health Risk |
Pathogenic |
— |
| RS2143746162 |
RAD51C
|
Health Risk |
Pathogenic/Likely pathogenic |
Fanconi anemia complementation group O, Breast-ovarian cancer |
| RS2143746632 |
RAD51C
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group O, Fanconi anemia complementation group O |
| RS2143746667 |
RAD51C
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group O, Breast-ovarian cancer |
| RS2143746939 |
RAD51C
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group O, Fanconi anemia complementation group O |
| RS2143747219 |
RAD51C
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group O, Fanconi anemia complementation group O |
| RS2143747561 |
RAD51C
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group O, Breast-ovarian cancer |
| RS2143747843 |
RAD51C
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia complementation group O, Hereditary cancer-predisposing syndrome |
| RS2143748292 |
RAD51C
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS2143748349 |
CCDC40
|
Health Risk |
Likely pathogenic |
Primary ciliary dyskinesia 15, Primary ciliary dyskinesia 15 |
| RS2143749742 |
RAD51C
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Fanconi anemia complementation group O |
| RS2143749861 |
RAD51C
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group O, Fanconi anemia complementation group O |
| RS2143751393 |
MKS1
|
Health Risk |
Pathogenic |
Joubert syndrome, Meckel-Gruber syndrome |
| RS2143753386 |
MKS1
|
Health Risk |
Pathogenic/Likely pathogenic |
Meckel syndrome, type 1 |
| RS2143755133 |
CCDC40
|
Health Risk |
Likely pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS2143756208 |
ZNF668
|
Health Risk |
Pathogenic |
marked facial dysmorphism, Profound global developmental delay |
| RS2143756871 |
MKS1
|
Health Risk |
Likely pathogenic |
Meckel-Gruber syndrome, Joubert syndrome |
| RS2143773909 |
NF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurofibromatosis, type 1 |
| RS2143773941 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2143774090 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2143774183 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2143774209 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2143774220 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2143774762 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2143775617 |
ACTG1
|
Health Risk |
Likely pathogenic |
Autosomal dominant nonsyndromic hearing loss 20, Autosomal dominant nonsyndromic hearing loss 20 |
| RS2143775658 |
ACTG1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hearing impairment, Hearing impairment |
| RS2143775764 |
ACTG1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant nonsyndromic hearing loss 20, Baraitser-winter syndrome 2 |
| RS2143775790 |
ACTG1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant nonsyndromic hearing loss 20, Baraitser-winter syndrome 2 |
| RS2143775813 |
ACTG1
|
Health Risk |
Likely pathogenic |
— |
| RS2143776740 |
ACTG1
|
Health Risk |
Likely pathogenic |
— |
| RS2143777099 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS2143777263 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2143777361 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2143777575 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2143777901 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2143777988 |
MKS1
|
Health Risk |
Pathogenic |
Meckel-Gruber syndrome, Joubert syndrome |
| RS2143778074 |
MKS1
|
Health Risk |
Pathogenic |
Meckel-Gruber syndrome, Joubert syndrome |
| RS2143778877 |
ACTG1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant nonsyndromic hearing loss 20, Autosomal dominant nonsyndromic hearing loss 20 |
| RS2143778936 |
HYDIN
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia 5, Primary ciliary dyskinesia 5 |
| RS2143779081 |
ACTG1
|
Health Risk |
Likely pathogenic |
Baraitser-winter syndrome 2, Baraitser-winter syndrome 2 |
| RS2143779222 |
ACTG1
|
Health Risk |
Likely pathogenic |
Autosomal dominant nonsyndromic hearing loss 20, Autosomal dominant nonsyndromic hearing loss 20 |
| RS2143779274 |
ACTG1
|
Health Risk |
Likely pathogenic |
Autosomal dominant nonsyndromic hearing loss 20, Autosomal dominant nonsyndromic hearing loss 20 |
| RS2143781646 |
CCDC40
|
Health Risk |
Likely pathogenic |
Primary ciliary dyskinesia 15, Primary ciliary dyskinesia 15 |
| RS2143782472 |
LAMA1
|
Health Risk |
Likely pathogenic |
Ataxia - intellectual disability - oculomotor apraxia - cerebellar cysts syndrome, Ataxia - intellectual disability - oculomotor apraxia - cerebellar cysts syndrome |
| RS2143782841 |
BCAS3
|
Health Risk |
Pathogenic/Likely pathogenic |
Global developmental delay, Hengel-Maroofian-Schols syndrome |
| RS2143783696 |
ACTG1
|
Health Risk |
Pathogenic |
Baraitser-winter syndrome 2, Baraitser-winter syndrome 2 |
| RS2143784739 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2143784912 |
PIEZO2
|
Health Risk |
Pathogenic |
— |
| RS2143784954 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2143785161 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2143785195 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2143785464 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2143785630 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2143785819 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2143785938 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2143786045 |
NF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurofibromatosis, type 1 |
| RS2143786053 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2143786096 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2143786188 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2143786248 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2143786391 |
NF1
|
Health Risk |
Pathogenic |
— |
| RS2143786639 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2143786875 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2143789412 |
CCDC40
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS2143792571 |
TBX4
|
Health Risk |
Likely pathogenic |
Pulmonary hypertension, primary |
| RS2143792602 |
TBX4
|
Health Risk |
Likely pathogenic |
Pulmonary hypertension, primary |
| RS2143792897 |
TBX4
|
Health Risk |
Likely pathogenic |
Pulmonary hypertension, primary |
| RS2143795994 |
TBX4
|
Health Risk |
Pathogenic/Likely pathogenic |
Pulmonary hypertension, primary |
| RS2143797889 |
RAD51C
|
Health Risk |
Pathogenic/Likely pathogenic |
Fanconi anemia complementation group O, Breast-ovarian cancer |
| RS2143797916 |
RAD51C
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS2143798127 |
RAD51C
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS2143798753 |
RAD51C
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS2143800709 |
RAD51C
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS2143800757 |
MKS1
|
Health Risk |
Pathogenic/Likely pathogenic |
Joubert syndrome, Meckel-Gruber syndrome |
| RS2143800981 |
MAF
|
Health Risk |
Likely pathogenic |
Cataract 21 multiple types, Cataract 21 multiple types |
| RS2143801496 |
RAD51C
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group O, Fanconi anemia complementation group O |
| RS2143801614 |
SMCHD1
|
Health Risk |
Pathogenic |
Muscle weakness, Facioscapulohumeral muscular dystrophy 2 |
| RS2143801795 |
RAD51C
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group O, Fanconi anemia complementation group O |
| RS2143801832 |
RAD51C
|
Health Risk |
Pathogenic |
— |
| RS2143802342 |
RAD51C
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia complementation group O, Fanconi anemia complementation group O |
| RS2143805609 |
MKS1
|
Health Risk |
Likely pathogenic |
Joubert syndrome, Meckel-Gruber syndrome |
| RS2143805963 |
SMCHD1
|
Health Risk |
Pathogenic |
Facioscapulohumeral muscular dystrophy 2, Facioscapulohumeral muscular dystrophy 2 |
| RS2143816916 |
MAF
|
Health Risk |
Likely pathogenic |
Cataract 21 multiple types, Cataract 21 multiple types |
| RS2143820144 |
MAP3K14
|
Health Risk |
Likely pathogenic |
NIK deficiency, NIK deficiency |
| RS2143820895 |
TBX4
|
Health Risk |
Conflicting classifications of pathogenicity |
Coxopodopatellar syndrome, Pulmonary hypertension |
| RS2143821228 |
TBX4
|
Health Risk |
Pathogenic |
Autosomal recessive amelia, Autosomal recessive amelia |
| RS2143821238 |
TBX4
|
Health Risk |
Likely pathogenic |
Pulmonary hypertension, primary |
| RS2143821653 |
LOXHD1
|
Health Risk |
Pathogenic |
— |